首站-论文投稿智能助手
典型文献
Myeloperoxidase: a new target for the treatment of stroke?
文献摘要:
Myeloperoxidase is an important inflammatory factor in the myeloid system, primarily expressed in neutrophils and microglia. Myeloperoxidase and its active products participate in the occurrence and development of hemorrhagic and ischemic stroke, including damage to the blood-brain barrier and brain. As a specific inflammatory marker, myeloperoxidase can be used in the evaluation of vascular disease occurrence and development in stroke, and a large amount of experimental and clinical data has indicated that the inhibition or lack of myeloperoxidase has positive impacts on stroke prognosis. Many studies have also shown that there is a correlation between the overexpression of myeloperoxidase and the risk of stroke. The occurrence of stroke not only refers to the first occurrence but also includes recurrence. Therefore, myeloperoxidase is significant for the clinical evaluation and prognosis of stroke. This paper reviews the potential role played by myeloperoxidase in the development of vascular injury and secondary brain injury after stroke and explores the effects of inhibiting myeloperoxidase on stroke prognosis. This paper also analyzes the significance of myeloperoxidase etiology in the occurrence and development of stroke and discusses whether myeloperoxidase can be used as a target for the treatment and prediction of stroke.
文献关键词:
作者姓名:
Yun-Chang Wang;Yu-Bao Lu;Xiao-Lan Huang;Yong-Feng Lao;Lu Zhang;Jun Yang;Mei Shi;Hai-Long Ma;Ya-Wen Pan;Yi-Nian Zhang
作者机构:
The Second Clinical Medical School,Lanzhou University,Lanzhou,Gansu Province,China;Department of Neurosurgery,Lanzhou University Second Hospital,Lanzhou,Gansu Province,China;Xiangya Hospital,Central South University,Changsha,Hunan Province,China;Department of Spine Surgery,The Third Affiliated Hospital,Sun Yat-sen University,Guangzhou,Guangdong Province,China;University of Chinese Academy of Sciences,Beijing,China
引用格式:
[1]Yun-Chang Wang;Yu-Bao Lu;Xiao-Lan Huang;Yong-Feng Lao;Lu Zhang;Jun Yang;Mei Shi;Hai-Long Ma;Ya-Wen Pan;Yi-Nian Zhang-.Myeloperoxidase: a new target for the treatment of stroke?)[J].中国神经再生研究(英文版),2022(08):1711-1716
A类:
B类:
Myeloperoxidase,new,target,treatment,stroke,important,inflammatory,myeloid,system,primarily,expressed,neutrophils,microglia,its,active,products,participate,occurrence,development,hemorrhagic,ischemic,including,damage,blood,brain,barrier,specific,marker,myeloperoxidase,used,evaluation,vascular,disease,large,amount,experimental,clinical,data,has,indicated,that,inhibition,lack,positive,impacts,prognosis,Many,studies,have,also,shown,there,correlation,between,overexpression,risk,not,only,refers,first,but,includes,recurrence,Therefore,significant,This,paper,reviews,potential,role,played,by,injury,secondary,after,explores,effects,inhibiting,analyzes,significance,etiology,discusses,whether,prediction
AB值:
0.50231
相似文献
Spirulina platensis aqueous extracts ameliorate colonic mucosal damage and modulate gut microbiota disorder in mice with ulcerative colitis by inhibiting inflammation and oxidative stress
Jian WANG;Liqian SU;Lun ZHANG;Jiali ZENG;Qingru CHEN;Rui DENG;Ziyan WANG;Weidong KUANG;Xiaobao JIN;Shuiqing GUI;Yinghua XU;Xuemei LU-Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances,School of Life Science and Biopharmaceutics,Guangdong Pharmaceutical University,Guangzhou 510006,China;School of Pharmacy,Guangdong Pharmaceutical University,Guangzhou 510006,China;Intensive Care Unit,Shenzhen Second People's Hospital,the First Affiliated Hospital of Shenzhen University,Shenzhen 518031,China;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products,National Institutes for Food and Drug Control,Beijing 102629,China
Deubiquitinase ubiquitin-specific protease 3 (USP3) inhibits HIV-1 replication via promoting APOBEC3G (A3G) expression in both enzyme activity-dependent and -independent manners
Zhao Simin;Zheng Baisong;Wang Liuli;Cui Wenzhe;Jiang Chunlai;Li Zhuo;Gao Wenying;Zhang Wenyan-Center for Pathogen Biology and Infectious Diseases, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, Jilin 130021, China;College of Life Science of Jilin University, Changchun, Jilin 130012, China;Department of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130012, China;Jilin Provincial Key Laboratory on Molecular and Chemical Genetics, The Second Hospital of Jilin University, Changchun, Jilin 130041, China;Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin 130021, China
Hybrid nanogenerator based closed-loop self-powered low-level vagus nerve stimulation system for atrial fibrillation treatment
Yu Sun;Shengyu Chao;Han Ouyang;Weiyi Zhang;Weikang Luo;Qingbin Nie;Jianing Wang;Changyi Luo;Gongang Ni;Lingyu Zhang;Jun Yang;Hongqing Feng;Gengsheng Mao;Zhou Li-Department of Neurosurgery,General Hospital of Armed Police Forces,Anhui Medical University,Hefei 230032,China;Department of Neurosurgery,The Third Medical Centre,Chinese People's Liberation Army General Hospital,Beijing 100039,China;Beijing Key Laboratory of Micro-nano Energy and Sensor,Beijing Institute of Nanoenergy and Nanosystems,Chinese Academy of Sciences,Beijing 101400,China;School of Nanoscience and Technology,University of Chinese Academy of Sciences,Beijing 100049,China;Institute of Integrative Medicine.Department of Integrated Traditional Chinese and Western Medicine,Xiangya Hospital,Central South University,Changsha 410008,China;Department of Neurosurgery,Peking University Third Hospital,Beijing 100191,China;School of Chemistry and Chemical Engineering,Center on Nanoenergy Research,Guangxi University,Nanning 530004,China;Institute for Stem Cell and Regeneration,Chinese Academy of Sciences,Beijing 100101,China
Neuronal chemokine-like-factor 1(CKLF1)up-regulation promotes M1 polarization of microglia in rat brain after stroke
Xin Zhou;Ya-ni Zhang;Fang-fang Li;Zhao Zhang;Li-yuan Cui;Hong-yuan He;Xu Yan;Wen-bin He;Hong-shuo Sun;Zhong-ping Feng;Shi-feng Chu;Nai-hong Chen-State Key Laboratory of Bioactive Substances and Functions of Natural Medicines,Institute of Materia Medica and Neuroscience Center,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Institute of Clinical Pharmacology&Science and Technology Innovation Center,Guangzhou University of Chinese Medicine,Guangzhou 510405,China;Tianjin University of Tradition Chinese Medicine,Tianjin 301617,China;Shanxi Key Laboratory of Chinese Medicine Encephalopathy,Shanxi University of Chinese Medicine,Jinzhong 030619,China;Department of Physiology,Faculty of Medicine,University of Toronto,Toronto,ON,Canada
Novel Caspase-1 inhibitor CZL80 improves neurological function in mice after progressive ischemic stroke within a long therapeutic time-window
Ling Pan;Wei-dong Tang;Ke Wang;Qi-feng Fang;Meng-ru Liu;Zhan-xun Wu;Yi Wang;Sun-liang Cui;Gang Hu;Ting-jun Hou;Wei-wei Hu;Zhong Chen;Xiang-nan Zhang-Institute of Pharmacology and Toxicology,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou 310058,China;Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province,School of Pharmaceutical Sciences,Zhejiang Chinese Medical University,Hangzhou 310053,China;Department of Pharmachemistry,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou 310058,China;Department of Pharmacology,School of Medicine and Life Sciences,Nanjing University of Chinese Medicine,Nanjing 210029,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。